Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments

Author： Hodgkins Paul   Dittmann Ralf W   Sorooshian Shaw   Banaschewski Tobias  

Publisher： Informa Healthcare

ISSN： 1473-7175

Source： Expert Review of Neurotherapeutics, Vol.13, Iss.4, 2013-04, pp. : 425-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen   Suzuki Alejandra R   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

New drugs for the treatment of attention-deficit/hyperactivity disorder

By Pataki Caroly S   Feinberg David T   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 293-302

Informa Healthcare

Access to resources Recommend Favorite

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

By  

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite

Neutraceuticals and Diet Restriction for the Treatment of Attention-Deficit/Hyperactivity Disorder

By  

Child and Adolescent Psychopharmacology News, Vol. 17, Iss. 5, 2012-10 ,pp. : 5-12

Guilford Publications Inc

Access to resources Recommend Favorite

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

By Kratochvil Christopher J   Vaughan Brigette S   Harrington Martin J   Burke William J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1165-1174

Informa Healthcare

Access to resources Recommend Favorite